Brief: Aurobindo Pharma Gets Tax Demand And Penalty Of 776.1 Million Rupees Each
13/03/2026 07:39
March 13 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: GETS TAX DEMAND AND PENALTY OF 776.1 MILLION RUPEES EACH Source text: ID:nBSEbyqSK8 Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11